Skip to main content
Top
Published in: Systematic Reviews 1/2015

Open Access 01-12-2015 | Research

Factors associated with development of gastrointestinal problems in patients with scleroderma: a systematic review

Authors: Brian Younho Hong, Raymond Giang, Lawrence Mbuagbaw, Maggie Larche, Lehana Thabane

Published in: Systematic Reviews | Issue 1/2015

Login to get access

Abstract

Background

Up to 90 % of people with scleroderma have gastrointestinal (GI) problems such as constipation, bloating, diarrhea, and malabsorption. These problems significantly impair quality of life. Our objective was to determine the risk factors for gastrointestinal issues in people with scleroderma.

Methods

We conducted a systematic review of observational studies that report GI problems in patients with scleroderma along with the associated risk factors. We were interested in any GI problem and any risk factor as long as the study included patients diagnosed with scleroderma according to the 1980 or 2013 American College of Rheumatology guideline. We searched the following databases: CINAHL, EMBASE, LILACS, MEDLINE, and Web of Science for relevant articles from June 1884 to May 2014. Two authors independently screened citations and full text articles and extracted data. Discrepancies were resolved by consensus or by consulting a third author. Methodological quality of included studies was assessed using the Newcastle-Ottawa Scale.

Results

After removing duplicates, 645 unique citations were identified. A total of three studies, three cross-sectional (n = 64, n = 42, n = 606), were included in this systematic review. Collectively, these three studies explored Helicobacter pylori and smoking status as risk factors. We found conflicting evidence on the role of H. pylori with two studies showing opposite yet statistically significant results. One moderate quality study showed smoking as a risk factor. Key limitations include the small sample sizes of two studies and poor study designs to draw causal links.

Conclusions

There is insufficient evidence to describe the risk factors for GI problems in patients with scleroderma. Longitudinal observational studies are warranted in patients with scleroderma.

Systematic review registration

Literature
1.
go back to reference Hansi N, Thoua N, Carulli M, Chakravarty K, Lal S, Smyth A, et al. Consensus best practice pathway of the UK scleroderma study group: gastrointestinal manifestations of systemic sclerosis. Clin Exp Rheumatol 2014;32:S-214-21. Hansi N, Thoua N, Carulli M, Chakravarty K, Lal S, Smyth A, et al. Consensus best practice pathway of the UK scleroderma study group: gastrointestinal manifestations of systemic sclerosis. Clin Exp Rheumatol 2014;32:S-214-21.
2.
go back to reference Al-Dhaher FF, Pope JE, Ouimet JM. Determinants of morbidity and mortality of systemic sclerosis in Canada. Semin Arthritis Rheum. 2010;39:269–77.CrossRefPubMed Al-Dhaher FF, Pope JE, Ouimet JM. Determinants of morbidity and mortality of systemic sclerosis in Canada. Semin Arthritis Rheum. 2010;39:269–77.CrossRefPubMed
3.
go back to reference Hachulla E, Launay D. Diagnosis and classification of systemic sclerosis. Clin Rev Allergy Immunol. 2011;40:78–83.CrossRefPubMed Hachulla E, Launay D. Diagnosis and classification of systemic sclerosis. Clin Rev Allergy Immunol. 2011;40:78–83.CrossRefPubMed
4.
5.
go back to reference Malcarne VL, Hansdottir I, McKinney A, Upchurch R, Greenbergs HL, Henstorf GH, et al. Medical signs and symptoms associated with disability, pain, and psychosocial adjustment in systemic sclerosis. J Rheumatol. 2007;34:359–67.PubMed Malcarne VL, Hansdottir I, McKinney A, Upchurch R, Greenbergs HL, Henstorf GH, et al. Medical signs and symptoms associated with disability, pain, and psychosocial adjustment in systemic sclerosis. J Rheumatol. 2007;34:359–67.PubMed
6.
go back to reference Ferri C, Valentini G, Cozzi F, Sebastiani M, Michelassi C, La Montagna G, et al. Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients. Medicine. 2002;81:139–53.CrossRefPubMed Ferri C, Valentini G, Cozzi F, Sebastiani M, Michelassi C, La Montagna G, et al. Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients. Medicine. 2002;81:139–53.CrossRefPubMed
7.
go back to reference Smith V, Riccieri V, Pizzorni C, Decuman S, Deschepper E, Bonroy C, et al. Nailfold capillaroscopy for prediction of novel future severe organ involvement in systemic sclerosis. J Rheumatol. 2014;40:2023–8.CrossRef Smith V, Riccieri V, Pizzorni C, Decuman S, Deschepper E, Bonroy C, et al. Nailfold capillaroscopy for prediction of novel future severe organ involvement in systemic sclerosis. J Rheumatol. 2014;40:2023–8.CrossRef
8.
go back to reference Smith V, Decuman S, Sulli A, Bonroy C, Piettte Y, Deschepper E, et al. Do worsening scleroderma capillaroscopic patterns predict future severe organ involvement? A pilot study. Ann Rheum Dis. 2012;71:1636–9.CrossRefPubMed Smith V, Decuman S, Sulli A, Bonroy C, Piettte Y, Deschepper E, et al. Do worsening scleroderma capillaroscopic patterns predict future severe organ involvement? A pilot study. Ann Rheum Dis. 2012;71:1636–9.CrossRefPubMed
9.
go back to reference Baron M, Bernier P, Cote F, Delegge MH, Falovitch G, Friedman G et al. Screening and management of malnutrition and related gastro-intestinal disorders in systemic sclerosis: recommendations of a North American expert panel. Clinical and Experimental Rheumatology. 2010; (Suppl. 58): S42-6. Baron M, Bernier P, Cote F, Delegge MH, Falovitch G, Friedman G et al. Screening and management of malnutrition and related gastro-intestinal disorders in systemic sclerosis: recommendations of a North American expert panel. Clinical and Experimental Rheumatology. 2010; (Suppl. 58): S42-6.
10.
go back to reference Khanna D, Nagaraja V, Gladue H, Chey W, Pimentel M, Frech T. Measuring response in the gastrointestinal tract in systemic sclerosis. Curr Opin Rheumatol. 2013;25:700–6.CrossRefPubMed Khanna D, Nagaraja V, Gladue H, Chey W, Pimentel M, Frech T. Measuring response in the gastrointestinal tract in systemic sclerosis. Curr Opin Rheumatol. 2013;25:700–6.CrossRefPubMed
11.
go back to reference Chifflot H, Fautrel B, Sordet C, Chatelus E, Sibilia J. Incidence and prevalence of systemic sclerosis: a systematic literature review. Semin Arthritis Rheum. 2008;37:223–35.CrossRefPubMed Chifflot H, Fautrel B, Sordet C, Chatelus E, Sibilia J. Incidence and prevalence of systemic sclerosis: a systematic literature review. Semin Arthritis Rheum. 2008;37:223–35.CrossRefPubMed
12.
go back to reference Nietert PJ, Richard S. Systemic sclerosis: environmental and occupational risk factors. Current Opinion in Rhuematology. 2000;12:520–6.CrossRef Nietert PJ, Richard S. Systemic sclerosis: environmental and occupational risk factors. Current Opinion in Rhuematology. 2000;12:520–6.CrossRef
13.
go back to reference Bernatsky S, Hudson M, Panopalis P, Clarke AE, Pope J, Leclercq S, et al. The cost of systemic sclerosis. Arthritis Care Res. 2009;61:119–23.CrossRef Bernatsky S, Hudson M, Panopalis P, Clarke AE, Pope J, Leclercq S, et al. The cost of systemic sclerosis. Arthritis Care Res. 2009;61:119–23.CrossRef
14.
go back to reference Agarwal SK, Tan FK, Arnett FC. Genetics and genomic studies in scleroderma (systemic sclerosis). Rheum Dis Clin N Am. 2008;34:17–40.CrossRef Agarwal SK, Tan FK, Arnett FC. Genetics and genomic studies in scleroderma (systemic sclerosis). Rheum Dis Clin N Am. 2008;34:17–40.CrossRef
15.
go back to reference Lidar M, Agmon-Levin N, Langevitz P, Shoenfeld Y. Silicone and scleroderma revisited. Lupus. 2012;21:121–7.CrossRefPubMed Lidar M, Agmon-Levin N, Langevitz P, Shoenfeld Y. Silicone and scleroderma revisited. Lupus. 2012;21:121–7.CrossRefPubMed
16.
go back to reference Wielosz E, Borys O, Zychowska I, Wielowieyska-Szybińska D, Zabińska-Płazak E, Kiełtyka A. Gastrointestinal involvement in patients with systemic sclerosis. Polish Archives Int Med. 2010;120:132–6. Wielosz E, Borys O, Zychowska I, Wielowieyska-Szybińska D, Zabińska-Płazak E, Kiełtyka A. Gastrointestinal involvement in patients with systemic sclerosis. Polish Archives Int Med. 2010;120:132–6.
17.
go back to reference Diot E, Lesire V, Guilmot JL, Metzger MD, Pilore R, Rogier S. Systemic sclerosis and occupational risk factors: a case-control study. Occup Environ Med. 2002;59:545–9.CrossRefPubMedPubMedCentral Diot E, Lesire V, Guilmot JL, Metzger MD, Pilore R, Rogier S. Systemic sclerosis and occupational risk factors: a case-control study. Occup Environ Med. 2002;59:545–9.CrossRefPubMedPubMedCentral
18.
go back to reference Marie I, Gehanno JF, Bubenheim M, Duval-Modeste AB, Joly P, Dominique S. Prospective study to evaluate the association between systemic sclerosis and occupational exposure and review of the literature. Autoimmun Rev. 2014;13:151–6.CrossRefPubMed Marie I, Gehanno JF, Bubenheim M, Duval-Modeste AB, Joly P, Dominique S. Prospective study to evaluate the association between systemic sclerosis and occupational exposure and review of the literature. Autoimmun Rev. 2014;13:151–6.CrossRefPubMed
19.
go back to reference Silman AJ. Epidemiology of scleroderma. Annals of Rheumatic Diseases. 1991;50:846–53.CrossRef Silman AJ. Epidemiology of scleroderma. Annals of Rheumatic Diseases. 1991;50:846–53.CrossRef
20.
go back to reference Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum. 1980;23:581-90. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum. 1980;23:581-90.
21.
go back to reference van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. 2013 classification criteria for systemic sclerosis. Ann Rheum Dis. 2013;72:1747–55.CrossRefPubMed van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. 2013 classification criteria for systemic sclerosis. Ann Rheum Dis. 2013;72:1747–55.CrossRefPubMed
22.
go back to reference Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25:603–5.CrossRefPubMed Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25:603–5.CrossRefPubMed
23.
go back to reference Deeks JJ, Altman DG, Bradburn MJ. Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. In: Egger M, Smith GD, Altman DG, editors. Systematic Reviews in Health Care. 2nd ed. London: BMJ Publishing; 2001. p. 285–312.CrossRef Deeks JJ, Altman DG, Bradburn MJ. Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. In: Egger M, Smith GD, Altman DG, editors. Systematic Reviews in Health Care. 2nd ed. London: BMJ Publishing; 2001. p. 285–312.CrossRef
24.
go back to reference Yamaguchi K, Iwakiri R, Hara M, Kikkawa A, Fujise T, Ootani H. Reflux esophagitis and Helicobacter pylori infection in patients with scleroderma. Intern Med. 2008;47:1555–9.CrossRefPubMed Yamaguchi K, Iwakiri R, Hara M, Kikkawa A, Fujise T, Ootani H. Reflux esophagitis and Helicobacter pylori infection in patients with scleroderma. Intern Med. 2008;47:1555–9.CrossRefPubMed
25.
go back to reference Hudson M, Steele R, Lu Y, Hercz D, Baron M, Steele R, et al. Cigarette smoking in patients with systemic sclerosis. Arthritis Rheum. 2011;63:230–8.CrossRefPubMed Hudson M, Steele R, Lu Y, Hercz D, Baron M, Steele R, et al. Cigarette smoking in patients with systemic sclerosis. Arthritis Rheum. 2011;63:230–8.CrossRefPubMed
26.
go back to reference Radic M, Kaliterna DM, Bonacin D, Vergles JM, Radić J, Fabijanić D, et al. Is Helicobacter pylori infection a risk factor for disease severity in systemic sclerosis? Rheumatol Int. 2013;33:2943–8.CrossRefPubMed Radic M, Kaliterna DM, Bonacin D, Vergles JM, Radić J, Fabijanić D, et al. Is Helicobacter pylori infection a risk factor for disease severity in systemic sclerosis? Rheumatol Int. 2013;33:2943–8.CrossRefPubMed
Metadata
Title
Factors associated with development of gastrointestinal problems in patients with scleroderma: a systematic review
Authors
Brian Younho Hong
Raymond Giang
Lawrence Mbuagbaw
Maggie Larche
Lehana Thabane
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Systematic Reviews / Issue 1/2015
Electronic ISSN: 2046-4053
DOI
https://doi.org/10.1186/s13643-015-0176-2

Other articles of this Issue 1/2015

Systematic Reviews 1/2015 Go to the issue